查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球鎳鈦合金醫療器材市場 -2023-2030
市場調查報告書
商品編碼
1373375

全球鎳鈦合金醫療器材市場 -2023-2030

Global Nitinol Medical Devices Market -2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

鎳鈦諾是鎳和鈦的等原子金屬合金，具有獨特的性能，包括超彈性或偽彈性和形狀記憶。鎳鈦諾的超彈性特性允許使用它的醫療設備壓縮至較低的輪廓。由鎳鈦合金製成的植入物（例如心臟瓣膜）在植入部位膨脹至預期尺寸和形狀並保留在患者體內。

支架、心臟瓣膜、導引線和腔靜脈過濾器等心血管裝置常使用鎳鈦合金。鎳鈦諾在其他設備領域的使用正在不斷成長，特別是對於用於微創手術的產品。

市場動態

增加產品發布

鎳鈦諾由於其高導熱性和生物相容性而常用於製造醫療器材。鎳鈦合金醫療器材產品的推出數量不斷增加，成為市場成長的重要推手。此外，許多主要參與者透過推出新的治療設備在市場的進步中發揮重要作用。

例如，2022 年 5 月，Stryker 推出了使用鎳鈦諾創建的 EasyFuse 動態壓縮系統，鎳鈦諾是一種以其強度和形狀恢復而聞名的鎳鈦合金金屬。

此外，2022 年 2 月，Medline UNITE 足踝部門在美國足踝外科醫師學會 (ACFAS) 年度科學會議上推出了 REFLEX 鎳鈦諾動態椎間盤系統。

此外，2021 年 5 月，Medline 推出了 REFLEX 鎳鈦合金釘系統。透過提高手術效率和提高植入物強度，此釘書釘旨在改善患者的治療效果。

此外，慢性病盛行率和發病率上升以及使用鎳鈦合金醫療設備進行微創手術的日益普及等重要成長動力預計將在預測期內推動市場發展。

替代金屬的可用性

其他金屬的供應可能會阻礙市場成長。醫療器械也可以由不銹鋼和鈷鉻合金等生物材料金屬製成，因為它們比鎳鈦諾便宜，而且銅基合金也更常用於醫療器械的製造。

目錄

第 1 章：方法與範圍

  • 研究方法論
  • 報告的研究目的和範圍

第 2 章：定義與概述

第 3 章：執行摘要

  • 按設備類型分類
  • 按應用程式片段
  • 最終用戶摘錄
  • 按地區分類

第 4 章：市場動態

  • 影響因素
    • 促進要素
      • 增加產品發布
      • YY
    • 限制
      • 替代金屬的可用性
      • YY
    • 機會
    • 影響分析

第 5 章：產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • DMI 意見

第 6 章：COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆發前的情景
    • 新冠疫情期間的情景
    • 新冠疫情後的情景
  • COVID-19 期間的定價動態
  • 供需譜
  • 疫情期間政府與市場相關的舉措
  • 製造商策略舉措
  • 結論

第 7 章：按裝置類型

  • 鎳鈦合金釘
  • 鎳鈦合金支架
  • 鎳鈦合金導絲
    • 正畸導絲
    • 內視鏡導絲
  • 鎳鈦合金過濾器
  • 鎳鈦合金籃
  • 鎳鈦合金導管

第 8 章：按應用

  • 骨科
  • 泌尿科
  • 血管
  • 牙科
  • 胃腸病學
  • 其他

第 9 章：最終用戶

  • 醫院
  • 專科診所
  • 門診手術中心
  • 其他

第 10 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 亞太其他地區
  • 中東和非洲

第 11 章：競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 12 章：公司簡介

  • Medtronic Plc.
    • 公司簡介
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • Arthrex Inc.
  • B. Braun Melsungen AG
  • Cook Medical Inc.
  • Zimmer Biomet Holdings Inc.
  • Terumo Medical Corporation
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Endosmart GmbH
  • WL Gore & Associates Inc.

第 13 章：附錄

簡介目錄
Product Code: MD1608

Overview

Nitinol is an equiatomic metal alloy of nickel and titanium with unique properties, including superelasticity or pseudoelasticity and shape memory. Nitinol's superelastic properties allow medical devices using it to compress to a lower profile. Implants made of nitinol such as heart valves expand to their intended size and shape at the site of implantation and remain inside the patient.

Cardiovascular devices like stents, heart valves, guidewires, and vena cava filters have frequently uses nitinol. The use of nitinol in other device areas is growing particularly for products intended for use in minimally invasive procedures.

Market Dynamics

Increasing product launches

Nitinol is commonly used in manufacturing medical device due to its high thermal conductivity and biocompatibility. The increasing number of product launches for nitinol medical devices acts as a significant driver for market growth. Also, many key players play a major role in the advancements of the market by launching new treatment devices.

For instance, in May 2022, Stryker launched its EasyFuse Dynamic Compression System created by using nitinol, a nickel-titanium alloy metal well known for its strength and shape recovery.

Also, in February 2022, Medline UNITE Foot & Ankle Division launched the REFLEX Nitinol Dynamic Disc System at the American College of Foot & Ankle Surgeons (ACFAS) Annual Scientific Conference.

Additionally, in May 2021, Medline launched the REFLEX Nitinol Staple System. By enhancing surgical efficiency and improving implant strength, this staple is intended to improve patient outcomes.

Furthermore, significant growth drivers such as the rising prevalence and incidence of chronic diseases, and the growing adoption of minimally invasive surgeries by using nitinol medical devices are expected to drive the market in the forecast period.

Availability of alternative metals

The availability of other metals can hamper the market growth. Medical devices can also be made from biomaterial metals like stainless steel and cobalt-chromium alloys because they are less expensive than nitinol, and also copper-based alloys are more also frequently used in the manufacturing of medical devices.

Segment Analysis

The global nitinol medical devices market is segmented based on device type, application, end users and region.

Nitinol Stents Accounted for Approximately 46.7% of the Market Share

Nitinol stent is shaped like a trumpet that allows excellent conformability to vessel anatomy and is designed for bifurcation lesions. Nitinol Stents are expected to hold the largest market share over the period forecast owing to increasing new nitinol stents launches and technical advancements.

For instance, in August 2022, Medtronic launched its new interventional offering for coronary artery disease (CAD) called Onyx Frontier drug-eluting stent (DES) which is designed to have an updated delivery system, improved flexibility, and lower crossing profile.

Additionally, in January 2022, Cook Medical received Breakthrough Device designation approval from the U.S FDA on a new drug-eluting stent for below the knee. This stent is used to treat patients suffering from chronic limb-threatening ischemia.

Geographical Analysis

North America is expected to hold a significant position in the global nitinol medical devices market share

The global nitinol medical devices market is segmented into North America, Europe, Asia Pacific, South America, Middle East, and Africa.

North America has maintained a significant market proportion due to factors such as the rising incidence of medical surgery procedures, and increasing product launches, this trend is anticipated to continue throughout the forecast period.

For instance, according to the HexaHealth report published in 2023, around 4,00,000 heart bypass surgeries are performed every year, and approximately 2,00,000 surgeries are performed in the United States. Hence, there is an increased demand for nitinol catheters and guidewires to be utilized in heart surgeries and help in the market growth.

According to the American Joint Replacement Registry (AJRR) 2022. The annual report of hip and knee replacement demonstrates an overall cumulative procedural volume growth of 14% compared to the previous year and includes over 2.8 million hip and knee procedures since 2012 from over 1,250 hospitals, and ambulatory surgery centers (ASCs). Hence, there is an increased demand for nitinol medical implants that can be used in arthroplasty procedures.

Additionally, in September 2020, MedShape, Inc. launched the DynaClip Forte Nitinol Bone Fixation System. It has a four-legged inline design and uses superelastic nickel-titanium (NiTiNOL) technology to match the mechanical and anatomical specifications of various high load-bearing applications, like tarsometatarsal (Lapidus) fusion.

COVID-19 Impact Analysis:

The COVID-19 pandemic has had a significant impact on the global nitinol medical devices market. The onset of the pandemic in early 2020 led to widespread lockdowns and restrictions, impacting regular diagnoses, treatments, device launches, and consultations worldwide. With the outbreak of the pandemic, many pharmaceutical or medical device manufacturing units faced labor shortages and were unable to travel to work due to lockdown restrictions. Therefore, owing to the above factors, the nitinol medical devices market is expected to be moderately affected over the forecast period.

Competitive Landscape

The major global players in the market include: Medtronic Plc., Arthrex Inc., B. Braun Melsungen AG, Cook Medical Inc., Zimmer Biomet Holdings Inc., Terumo Medical Corporation, Boston Scientific Corporation, Abbott Laboratories, Endosmart GmbH, W. L. Gore & Associates Inc. among others.

Key Developments

  • In October 2023, Resonetics closed its $900 million acquisition of the SAES Getters medical nitinol business. The Smart Materials business creates raw nitinol alloys from nickel and titanium and produces nitinol wires, bars, ribbons, and sheets.
  • In March 2023, Medtronic received a CE Mark for the Affera Mapping and Ablation System, which includes the Sphere-9 Catheter and the Affera Prism-1 Mapping Software. With its 9mm Nitinol ablation tip, the all-in-one catheter can treat fewer focal ablation lesion administrations.
  • In April 2021, DJO acquired MedShape, Inc., where it uses its unique superelastic nickel-titanium form memory alloy and shape memory polymer technology to offer cutting-edge surgical solutions for foot and ankle surgeons.

Why Purchase the Report?

  • To visualize the global nitinol medical devices market segmentation based on device type, application, end users, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of nitinol medical devices market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global nitinol medical devices market report would provide approximately 61 tables, 64 figures, and 185 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Device Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End Users
  • 3.4. Snippet by Region

4. Market Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing product launches
      • 4.1.1.2.
    • 4.1.2. Restraints
      • 4.1.2.1. Availability of alternative metals
      • 4.1.2.2.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Device Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 7.1.2. Market Attractiveness Index, By Device Type
  • 7.2. Nitinol Staples*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Nitinol Stents
  • 7.4. Nitinol Guidewires
    • 7.4.1. Orthodontic Guidewires
    • 7.4.2. Endoscopic Guidewires
  • 7.5. Nitinol Filters
  • 7.6. Nitinol Basket
  • 7.7. Nitinol Catheters

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Orthopedic*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Urology
  • 8.4. Vascular
  • 8.5. Dental
  • 8.6. Gastroenterology
  • 8.7. Others

9. By End Users

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
    • 9.1.2. Market Attractiveness Index, By End Users
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Specialty Clinics
  • 9.4. Ambulatory Surgical Centers
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Medtronic Plc.
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Arthrex Inc.
  • 12.3. B. Braun Melsungen AG
  • 12.4. Cook Medical Inc.
  • 12.5. Zimmer Biomet Holdings Inc.
  • 12.6. Terumo Medical Corporation
  • 12.7. Boston Scientific Corporation
  • 12.8. Abbott Laboratories
  • 12.9. Endosmart GmbH
  • 12.10. W. L. Gore & Associates Inc.

LIST NOT EXHAUSTIVE.

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us